Cannabis Strategic Ventures (NUGS)
0.00
USD |
OTCM |
Apr 22, 16:00
Cannabis Strategic Ventures Cash from Operations (TTM): -8.562M for June 30, 2020
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2020 | -8.562M |
| March 31, 2020 | -7.643M |
| December 31, 2019 | -6.703M |
| September 30, 2019 | -5.106M |
| June 30, 2019 | -2.748M |
| March 31, 2019 | -2.532M |
| December 31, 2018 | -1.429M |
| Date | Value |
|---|---|
| September 30, 2018 | -1.123M |
| June 30, 2018 | -0.7177M |
| March 31, 2018 | -0.529M |
| December 31, 2017 | -0.2079M |
| September 30, 2017 | -0.0637M |
| June 30, 2017 | -0.0355M |
| March 31, 2017 | -0.017M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-8.562M
Minimum
Jun 2020
-2.748M
Maximum
Jun 2019
-6.152M
Average
-6.703M
Median
Dec 2019
Cash from Operations (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.00M |
| Oragenics Inc | -7.291M |